MedTrace Logo

The ATLAST Long-Term Study

NCT01476917 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2012-11-07

No results posted yet for this study

Summary

The Study is a multi-center, prospective, open label, single-arm, three-month, long-term study of the Attune Sleep Apnea System for the treatment of obstructive sleep apnea (OSA). The objective of the study is to monitor long-term use of the Attune Sleep Apnea System.

Conditions

  • Obstructive Sleep Apnea (OSA)

Interventions

DEVICE

Attune Sleep Apnea System

Observation of Attune Sleep Apnea System for use during sleep.

Sponsors & Collaborators

  • ApniCure, Inc.

    lead INDUSTRY

Principal Investigators

  • Ian Colrain, PhD · Stanford Research Institute (SRI)

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-06-30
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476917 on ClinicalTrials.gov